Disease Info Card

Gangliosidosis Gm1

Information about Gangliosidosis Gm1: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Gangliosidosis Gm1

Most recent studies have shown that Gangliosidosis Gm1 shares some biological mechanisms with beta-galactosidase-deficiency, dog-diseases, gangliosidoses, gangliosidoses-gm2, gangliosidosis-generalized-gm1-type-1-(disorder), gaucher-disease, inborn-errors-of-metabolism, leukodystrophy, lipoidosis, lysosomal-storage-diseases, mucolipidoses, mucopolysaccharidoses, mucopolysaccharidosis-iv, mucopolysaccharidosis-type-ivb, nerve-degeneration, nervousness, niemann-pick-diseases, sandhoff-disease, storage-disease, tay-sachs-disease.

Among the many pathways, these few ones have gauged particular interests from scientists studying Gangliosidosis Gm1, and have been seen in publications frequently: Autophagy, Choline Transport, Elastic Fiber Assembly, Excretion, Glycosylation, Intracellular Transport, Lipid Storage, Localization, Methylation, Myelination, Ossification, Pathogenesis, Phagocytosis, Pigmentation, Proteolysis, Reflex, Secretion, Translation, Transport, Tropism

Quite a number of genes have been found to play important roles in Gangliosidosis Gm1, such as ARSA, CAT, CHRM1, CRAT, CSF2, CTLA4, CTSA, EBP, GALC, GLB1, GLYAT, HLA-DQA1, LAMC2, MTCH1, NOD2, NPC1, PPP1R3A, PSAP, SH3D19. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.